Niquitin Mini (Nicotine)

Nicotine, the active ingredient in Niquitin Mini, is a nicotine replacement therapy presented as an oromucosal formulation for oromucosal use. It treats nicotine dependence and helps adult smokers quit by reducing withdrawal symptoms and cravings.

GNH USA supplies Niquitin Mini as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies, hospitals and clinics worldwide, ensuring quality, regulatory compliance and reliable logistics for global distribution.

Niquitin Mini is used in nicotine replacement therapy to support smoking cessation and manage nicotine dependence.

- Smoking cessation: helps reduce cravings and withdrawal symptoms, facilitating quitting. - Nicotine dependence: provides controlled nicotine delivery to lessen addiction. - Tobacco withdrawal: alleviates physiological and psychological withdrawal effects.

Niquitin Mini may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Mouth irritation: mild soreness or tingling in the oral cavity. - Nausea: occasional upset stomach. - Hiccups: brief episodes after use.

Serious or Rare Side Effects: - Allergic reaction: rash, swelling, or difficulty breathing. - Chest pain: unexpected discomfort in the chest area. - Rapid heart rate: noticeable increase in pulse.

Before using Niquitin Mini, consider the following precautions to ensure safe and effective use.

- Cardiovascular assessment: evaluate heart disease history before use. - Use as directed: follow prescriber instructions for dosage and duration. - Non‑smokers: not intended for individuals who do not use tobacco. - Concomitant nicotine products: avoid using other nicotine replacement therapies simultaneously. - Pregnancy and breastfeeding: consult a healthcare professional before use. - Store at room temperature: keep in original packaging, protect from moisture and heat.

Niquitin Mini can interact with certain medicines; awareness of these interactions helps prevent adverse effects.

Major Interactions (Avoid): - Other nicotine replacement products: risk of nicotine overdose. - Bupropion: combined use may increase seizure risk. - Certain vasoconstrictors (e.g., pseudoephedrine): may elevate cardiovascular strain.

Moderate Interactions (Monitor Closely): - CYP2A6 inhibitors (e.g., ketoconazole): may alter nicotine metabolism. - Alcohol: can increase nicotine cravings and affect metabolism. - SSRIs (e.g., fluoxetine): may modify nicotine clearance.